STXBP2 anticorps (C-Term)

N° du produit ABIN5533441

Cet anticorps anti-STXBP2 est un anticorps Lapin Polyclonal détectant STXBP2 dans WB. Adapté pour Humain.

Aperçu rapide pour STXBP2 anticorps (C-Term) (ABIN5533441)

Antigène: STXBP2 (Syntaxin Binding Protein 2 (STXBP2))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp STXBP2 est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-STXBP2 anticorps

Épitope: AA 440-469, C-Term

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This STXBP2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 440-469 amino acids from the C-terminal region of human STXBP2.

Isotype: Ig Fraction

Information d'application

Indications d'application: For WB starting dilution is: 1:1000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: Supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Détails sur STXBP2

Antigène: STXBP2 (Syntaxin Binding Protein 2 (STXBP2))

Autre désignation: STXBP2

Sujet: STXBP2 is involved in intracellular vesicle trafficking and vesicle fusion with membranes. Contributes to the granule exocytosis machinery through interaction with soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins that regulate membrane fusion. Regulates cytotoxic granule exocytosis in natural killer (NK) cells.

Poids moléculaire: 66 kDa

ID gène: 6813

UniProt: Q15833

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Synaptic Vesicle Exocytosis